User loginNavigation |
admin's blogEmergent BioSolutions Hosts Symposium for Biomedical Research ScholarsROCKVILLE, Md., Aug 24, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today hosted “Looking Beyond the Bench,” a symposium organized for doctoral students enrolled in the NIH-Oxford-Cambridge Scholars Program. The symposium featured Emergent executives, who, based on their extensive experience in the biopharmaceutical industry, provided insight on potential career paths awaiting biomedical researchers.
Submitted by admin on Mon, 08/30/2010 - 07:34. categories [ ]
Colman McCarthy to Receive 2010 EL-HIBRI Peace Education PrizeAugust 17, 2010 — The El-Hibri Charitable Foundation announced today that prominent peace educator, nationally renowned columnist and accomplished author Colman McCarthy has been selected as the recipient of the 2010 El-Hibri Peace Education Prize. The Prize, which carries a monetary award of $15,000, is given annually by the foundation to honor an individual or organization that has made a significant contribution to the field of peace education.
Submitted by admin on Mon, 08/23/2010 - 08:18. categories [ ]
Emergent BioSolutions to Acquire Trubion Pharmaceuticals
ROCKVILLE, Md., Aug 12, 2010 (BUSINESS WIRE) –
Submitted by admin on Thu, 08/19/2010 - 06:27. categories [ ]
Emergent Revises Upward 2010 Financial ForecastCompany anticipates total revenues of $275 to $300 million and net income of $40 to $50 million
Submitted by admin on Tue, 08/03/2010 - 10:35. categories [ ]
Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing FacilityROCKVILLE, MD, July 16, 2010 – Emergent BioSolutions Inc.
Submitted by admin on Tue, 07/27/2010 - 12:39. categories [ ]
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThraxROCKVILLE, Md., Jul 14, 2010 Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax(R) (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company’s large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
Submitted by admin on Thu, 07/15/2010 - 15:53. categories [ ]
The El-Hibri Foundation Launches WebsiteThe El-Hibri Foundation is a nonprofit organization with the goal of fostering dialogue between various religions and encouraging nonviolent solutions to global challenges affecting humankind. The Foundation has a new website at www.elhibrifoundation.org.
Submitted by admin on Wed, 07/14/2010 - 12:01. categories [ ]
Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO ParliamentariansROCKVILLE, Md., Jul 12, 2010 (BUSINESS WIRE) –
Submitted by admin on Tue, 07/13/2010 - 09:34. categories [ ]
Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign GovernmentsROCKVILLE, MD, June 24, 2010 – Emergent BioSolutions Inc.
Submitted by admin on Wed, 07/07/2010 - 12:00. categories [ ]
Emergent BioSolutions to Participate in June 2010 Investor ConferencesFuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:
Submitted by admin on Mon, 06/07/2010 - 15:34. categories [ ]
|
Category CloudTag CloudWho's new
Who's onlineThere are currently 0 users and 1 guest online.
Recent comments
|